The Evolution of RBQM & RBM in Clinical Research

How To Leverage RBQM Software In Your Next Trial

Before, it was about RBM. Now, it’s about Risk-Based Quality Management (RBQM) systems, an ICH- and FDA-advocated approach to managing risk for the entire clinical trial lifecycle. CluePoints provides the enabling technology and expertise to drive this new paradigm. Contact us to discover how CluePoints drives RBQM in clinical trials or to request a demo of our platform.

Why RBQM from Cluepoints?

As the pioneer in Risk-Basked Quality Management (RBQM) solutions, we offer sponsors and
CROs a better way to identify, visualize, manage, and document trial risks that could
compromise patient safety or delay the approval of Investigational Products.

clipboard

RISK-BASED QUALITY
MANAGEMENT SOLUTIONS

Cloud-based solutions designed to
give you complete oversight of
critical study metrics from one
convenient dashboard

 

clerical

CENTRAL STATISTICAL
MONITORING

 Unique algorithms that
interrogate clinical and operational
data in real time and illuminate
outliers and anomalies

 

stratigic

STRATEGIC PROFESSIONAL
SERVICES TEAM

 Leader in RBM/RBQM implementation,
site risk and readiness inspection, and
the processes of mergers and acquisitions

 

RBQM Made Easy: Grab Your Exclusive Resources Now!

Group 594@2x-1

RBQMLIVE

RBQM 2023 On-Demand

VIEW NOW

Group 593@2x

REPORT

REPORT Tufts Center For The Study Of Drug Development Impact Report

VIEW NOW

Group 592@2x-1

CASE STUDY

CASE STUDY How CluePoints Enabled Pfizer’s ‘Hyperspeed’ Vaccine

VIEW NOW

bubbles

 

What Happens When
You Boil the Ocean?

You get bubbles. Our RBQM solutions are designed to handle thousands of data points, bringing outliers to the forefront in bubble plots. With a comprehensive RBQM solution, you can immediately visualize thriving or declining studies, make quick risk-based management assessments around product or therapy performance, and take immediate action. Clinical trial time is precious. Don’t waste it.

Understanding New Sources Of Risk In Decentralized Trials

Decentralized trials aren’t going anywhere. Understand new risks related to end-user error or misuse and flawed technology.

  • New Entities With Accountabilities
  • loupe
    INVESTIGATOR
  • user
    PARTICIPANT
  • nursing-home
    HOME HEALTHCARE PROVIDER
  • medicine
    LOCAL PHARMACY
  • g948
    LOCAL IMAGING/LABS
  • Additional Modalities Of Data Collection
  • medical-app
    TELEMEDICINE
  • g2133
    ECOA
  • smartwatch
    WEARABLE & CONNECTED DEVICES
  • vaccine
    SELF-DIRECTED USE OF IMP
  • Medical Record
    EHR DATA